Oorsprong van het eerstegraads netwerk van Vladimir Bogin
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Batu Biologics, Inc.
Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA.
6
| Private Company | Pharmaceuticals: Major | 6 |
Subsidiary | Medical Specialties | 5 | |
Nobilis Therapeutics, Inc.
Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Vladimir Bogin via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AETHLON MEDICAL, INC. | Medical Specialties | Investor Relations Contact | |
ONCOLOGY PHARMA INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
ALBION KAY VCT PLC | Investment Managers | Director/Board Member | |
REGEN BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Boston University | College/University | Graduate Degree | |
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
DePaul University | College/University | Masters Business Admin | |
Northern Illinois University | College/University | Undergraduate Degree | |
The University of Waterloo | College/University | Undergraduate Degree | |
University of Western Ontario | College/University | Graduate Degree | |
Moscow State University Lomonosov | College/University | Doctorate Degree | |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
The University of Wales | College/University | Doctorate Degree | |
CYNATA THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
SCANCELL HOLDINGS PLC | Biotechnology | Director/Board Member Chairman | |
Tolerotech, Inc.
Tolerotech, Inc. Medical SpecialtiesHealth Technology ToleroTech Technology, Inc. operates as a biopharmaceutical firm. It develops and commercializes different medical products. The company was founded by Thomas E. Ichim and is headquartered in London, Canada. | Medical Specialties | Founder | |
MedVax Pharma Corp. | Chief Executive Officer | ||
Vendevia Group | Corporate Officer/Principal | ||
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer | |
Juvenile Diabetes Research Foundation Ltd.
Juvenile Diabetes Research Foundation Ltd. Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Ltd. is a British company that engages in the prevention, treatment, causes, and cure for diabetes. The CEO of the non-profit company is Karen Addington. | Miscellaneous Commercial Services | Chief Executive Officer | |
Society of Clinical Research Associates | Corporate Officer/Principal | ||
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Pharmaceuticals: Other | Director/Board Member | |
SIENNA CANCER DIAGNOSTICS LIMITED | Biotechnology | Director/Board Member | |
ADALTA LIMITED | Biotechnology | Director/Board Member | |
Selena Pharmaceuticals, Inc. | Founder | ||
Biorasi LLC
Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Biotechnology | Founder | |
Oncomune LLC | Founder | ||
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Creative Medical Health, Inc.
Creative Medical Health, Inc. Pharmaceuticals: OtherHealth Technology Creative Medical Health, Inc. manufactures bionutraceutical products. It portfolio of stem cell treatments including our patented caver stem, procedure for the treatment of erectile dysfunction with the use of the patients own stem cells, treatment of Type 2 diabetes, degenerative disc disease, cardio vascular disease and autoimmune diseases all utilize cutting edge stem cell technology, developed by leaders in the fields of Science and Medicine. The company is headquartered in Phoenix, AZ. | Pharmaceuticals: Other | Director/Board Member | |
Riordan Clinic Inc | Director/Board Member | ||
Saint Petersburg State University of Economics | College/University | Graduate Degree | |
University of Science, Arts & Technology | College/University | Doctorate Degree | |
Coma Research Institue | Director/Board Member | ||
Creative Medical Technologies, Inc.
Creative Medical Technologies, Inc. BiotechnologyHealth Technology Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ. | Biotechnology | President | |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Newstar Ventures Ltd. | Founder | ||
BERONI GROUP LIMITED | Biotechnology | Director/Board Member | |
N4 PHARMA PLC | Biotechnology | Chairman | |
Emvolio, Inc.
Emvolio, Inc. Pharmaceuticals: MajorHealth Technology Emvolio, Inc. develops cancer drugs. | Pharmaceuticals: Major | Chief Executive Officer | |
Biotherapy Services Ltd.
Biotherapy Services Ltd. Pharmaceuticals: MajorHealth Technology Biotherapy Services Ltd. specializes in wound healing and tissue regeneration using blood-derived products that contain white blood cells and platelets to harness the body's healing properties. The British company is developing the rapid™ biodynamic haematogel wound treatment for complex and slow healing wounds such as diabetic foot ulcers and pressure sores. The treatment is made up of concentrated platelets derived from the patient's own blood, which are activated by autologous thrombin to release healing growth factors, cell signaling molecules, and proteins that work at a cellular level. | Pharmaceuticals: Major | Chairman | |
Prophecy.io
Prophecy.io Packaged SoftwareTechnology Services Prophecy.io operates as a provider of a SaaS based low code data engineering platform. The company was founded by Raj Bains, Maciej Szpakowski and Vikas Marwaha and is headquartered in Palo Alto, CA. | Packaged Software | Chairman | |
MarrowTech Pharma, Inc. | General Counsel | ||
Batu Centre For Leukemia Research | President | ||
Carbon Manna UC | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 28 |
Verenigd Koninkrijk | 9 |
Canada | 7 |
Australië | 6 |
Rusland | 3 |
Sectoraal
Health Technology | 23 |
Consumer Services | 10 |
Commercial Services | 5 |
Finance | 2 |
Technology Services | 2 |
Operationeel
Director/Board Member | 55 |
Chief Executive Officer | 15 |
President | 14 |
Independent Dir/Board Member | 14 |
Chairman | 11 |
Sterkste connecties
Insiders | |
---|---|
Alan J. Lewis | 33 |
John Chiplin | 26 |
Thomas Ichim | 24 |
Vijay Mahant | 4 |
Roger M. Nocera | 3 |
Lisa Brock | 3 |
John Paul Salvador | 3 |
Vladimir Zaharchook | 3 |
Sergey O. Sablin | 3 |
John Peck | 3 |
Dimitri Theofilopoulos | 1 |
Yan Stillman | 1 |
- Beurs
- Insiders
- Vladimir Bogin
- Bedrijfsconnecties